RecruitingNot ApplicableNCT07220655
Cognition and Ultrasound
Sponsor
University of Minnesota
Enrollment
100 participants
Start Date
Jun 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Our primary goal is to investigate the role of Low-Intensity Focused Ultrasound (LIFU) neuromodulation on deep brain targets, and its potential to improve cognition
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- years of age or older
- Speak English (as assessed by their ability to read/answer survey questions)
- May be required to score in the appropriate range on self-report measures
Exclusion Criteria5
- They have a neurological disorder which may impact their fMRI scan or cause their reaction to LIFU to differ from that of healthy adults.
- They take any psychoactive medication.
- They are unable to undergo fMRI scanning due to a contraindication such as claustrophobia, unremovable piercings, pregnancy, the presence of medical devices such as pacemakers, or a movement or sleep disorder.
- Are pregnant, or may have reason to believe that they are pregnant.
- They have a diagnosis of a psychiatric condition other than depression or anxiety
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICELow-Intensity Focused Ultrasound (FUS or LIFU)
We will use an established, currently-marketed device to deliver LIFU neuromodulation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07220655
Related Trials
A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants
NCT076418811 location
A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults
NCT076224331 location
Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
NCT075390901 location
Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
NCT071106101 location
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
NCT070136432 locations